Many expectant moms are unaware of the dangers of cannabis use.
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...
Mike Hsu aims to stoke the consumer company’s growth by veering into Kenvue’s higher-margin but risky health products.
GlobalData on MSN
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...
Tylenol faces scrutiny over pregnancy use and autism links, despite scientific bodies finding no firm evidence. While ...
Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band ...
The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...
Parents deserve honest, evidence-based communication that acknowledges the many factors that contribute to a given child’s ...
2hon MSN
Kimberly-Clark Snaps Up Tylenol Maker Kenvue in £30 Billion Takeover Amid Autism Controversy
A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Kimberly-Clark Corp, the company behind popular brands like Kleenex and Huggies, has announced its plan to acquire Kenvue Inc ...
Kimberly-Clark said the combination would create a company with $32 billion in revenue and allow it to surpass Unilever Plc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results